Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts
- PMID: 36525594
- PMCID: PMC9887624
- DOI: 10.2337/dci22-0052
Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts
Comment on
-
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148. Diabetes Care. 2023. PMID: 36356111
References
-
- Bezin J, Gouverneur A, Pénichon M, et al. . GLP-1 receptor agonists and the risk of thyroid cancer. Diabetes Care 2023;46:384–390 - PubMed
-
- Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature 2019;567:305–307 - PubMed
-
- Alves C, Batel-Marques F, Macedo AF. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer. Diabetes Res Clin Pract 2012;98:271–284 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical